These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 39154)

  • 1. Specific binding of [3H]sulpiride to rat striatal preparations.
    Theodorou A; Crockett M; Jenner P; Marsden CD
    J Pharm Pharmacol; 1979 Jun; 31(6):424-6. PubMed ID: 39154
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of guanosine nucleotides of [3H]sulpiride binding to rat striatal membranes.
    Freedman SB; Poat JA; Woodruff GN
    Eur J Pharmacol; 1981 Jan; 69(1):117-8. PubMed ID: 7202509
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of [3H]sulpiride to purified rat striatal synaptic membranes.
    Woodruff GN; Freedman SB
    Neuroscience; 1981; 6(3):407-10. PubMed ID: 7219722
    [No Abstract]   [Full Text] [Related]  

  • 4. The characterization of [3H]sulpiride binding sites in pig striatal membranes.
    Holden-Dye L; Poat JA; Senior K; Woodruff GN
    Biochem Pharmacol; 1985 Aug; 34(16):2905-9. PubMed ID: 4026877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
    Theodorou AE; Hall MD; Jenner P; Marsden CD
    J Pharm Pharmacol; 1980 Jun; 32(6):441-4. PubMed ID: 6106685
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons.
    Theodorou A; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1981 Jul; 33(7):439-44. PubMed ID: 6115030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations.
    Freedman SB; Poat JA; Woodruff GN
    J Neurochem; 1981 Sep; 37(3):608-12. PubMed ID: 7276943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the localization of [3H]sulpiride binding sites in rat striatal membranes.
    Freedman SB; Mustafa AA; Poat JA; Senior KA; Wait CP; Woodruff GN
    Neuropharmacology; 1981 Dec; 20(12A):1151-5. PubMed ID: 6119635
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of some of the properties of the [3H]-sulpiride binding site in soluble and native membrane preparations of dog striatum.
    Templeton WW; Woodruff GN
    Br J Pharmacol; 1983 Jan; 78(1):5-7. PubMed ID: 6824816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H] (-)sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay.
    Stefanini E; Ortu AM; Vernaleone F; Gessa GL
    Pharmacol Res Commun; 1987 Nov; 19(11):777-91. PubMed ID: 3444842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of sodium and sulphydryl groups on [3H]sulpiride binding sites in rat striatal membranes.
    Freedman SB; Poat JA; Woodruff GN
    J Neurochem; 1982 May; 38(5):1459-65. PubMed ID: 7062062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites.
    Theodorou AE; Jenner P; Marsden CD
    Life Sci; 1983 Mar; 32(11):1243-54. PubMed ID: 6834988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characterization of [3H]sulpiride binding sites in rat striatal membranes.
    Imafuku J
    Brain Res; 1987 Feb; 402(2):331-8. PubMed ID: 3828800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs.
    Csernansky JG; Csernansky CA; Hollister LE
    Experientia; 1985 Nov; 41(11):1419-21. PubMed ID: 4065296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.